Testicular cancer is the most common solid malignancy among males aged 15 to 40 years in the US, with approximately 10 000 new cases diagnosed each year. Between 90% and 95% of testicular cancers are ...

Northwestern Medicine scientists have uncovered a key pathway controlling tumor growth in B-cell lymphomas, according to a ...

Among Hispanic patients, the age-standardized incidence rate of testicular germ cell tumors rose from 3.22 per 100,000 person-years in 1992 to 7.58 per 100,000 person-years in 2021. The incidence ...

Germ Cell Tumor Market Outlook 2025-2035: The 7 major germ cell tumor market reached a value of USD 1.6 Billion in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 4.2 Billion by 2035, ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

For solid tumors, however, the efficacy of CAR T-cell treatments has been limited and progress “more incremental,” Christian Hinrichs, MD, with Rutgers Cancer Institute in New Brunswick ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research led by investigators at the Johns Hopkins Kimmel ...

The presence of a robust antitumor milieu characterized by an abundance of CD8+ cytotoxic T-cells ... immunohistochemistry scoring approach. In conclusion, the recent success of immune-based ...

They arise from the tissue that lines the ovaries or fallopian tubes and they include low grade and high grade tumor types. These cancers should be treated with surgery, radiation, targeted therapy, ...

IHC: Immunohistochemistry; NSCLC: Non-small-cell lung cancer. Adapted with permission from [77]. The authors have no relevant affiliations or financial involvement with any organization or entity ...